BackOrtho Clinical Diagnostics Holdings plc Overview

Ortho Clinical Diagnostics Holdings plc Selling, General & Admin

See how OCDX's SG&A expenses trends over time vs similar companies.

Get informed when a big investor buys or sells

+ Follow

Quarterly SG&A Expenses

$129.50M
1.52% YoY

As of Apr 3, 2022

Annual SG&A Expenses (TTM)

$553.10M
9.81% YoY

Trailing 12 months ending Apr 3, 2022

Average SG&A Expenses (Comparison Companies)

Selling, General & Admin History

Selling, General & Admin Comparison

Annual Selling, General & Admin Growth Rate (%)

Annual Selling, General & Admin Growth (Absolute)

Ortho Clinical Diagnostics Holdings plc (OCDX) FAQ

Stockcircle tracks selling, general & admin for Ortho Clinical Diagnostics Holdings plc (OCDX), including historical charts and peer comparisons when data is available. Check back as new filings are published, or open the stock overview for a broader fundamental snapshot.

This Selling, General & Admin page is built for Ortho Clinical Diagnostics Holdings plc's historical SG&A expenses trend and peer context. When enough reporting periods are on file, the charts below visualize how the metric has moved over time.

Use SG&A expenses as one input alongside growth, profitability, valuation, and ownership activity. Stockcircle links related metric pages and the main OCDX overview so you can move from this figure to the surrounding analysis quickly.